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Abstract
Background: Dysfunction of brain-gut interaction is thought to underlie visceral hypersensitivity which causes
unexplained abdominal pain syndromes. However, the mechanism by which alteration of brain function in the
brain-gut axis influences the perception of visceral pain remains largely elusive. In this study we investigated
whether altered brain activity can generate visceral hyperalgesia.
Results: Using a forebrain specific aCaMKII promoter, we established a line of transgenic (Tg) mice expressing a
dominant-negative pore mutant of the Kv7.2/KCNQ2 channel which suppresses native KCNQ/M-current and
enhances forebrain neuronal excitability. Brain slice recording of hippocampal pyramidal neurons from these Tg
mice confirmed the presence of hyperexcitable properties with increased firing. Behavioral evaluation of Tg mice
exhibited increased sensitivity to visceral pain induced by intraperitoneal (i.p.) injection of either acetic acid or
magnesium sulfate, and intracolon capsaicin stimulation, but not cutaneous sensation for thermal or inflammatory
pain. Immunohistological staining showed increased c-Fos expression in the somatosensory SII cortex and insular
cortex of Tg mice that were injected intraperitoneally with acetic acid. To mimic the effect of cortical
hyperexcitability on visceral hyperalgesia, we injected KCNQ/M channel blocker XE991 into the lateral ventricle of
wild type (WT) mice. Intracerebroventricular injection of XE991 resulted in increased writhes of WT mice induced
by acetic acid, and this effect was reversed by co-injection of the channel opener retigabine.
Conclusions: Our findings provide evidence that forebrain hyperexcitability confers visceral hyperalgesia, and
suppression of central hyperexcitability by activation of KCNQ/M-channel function may provide a therapeutic
potential for treatment of abdominal pain syndromes.
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Background
Visceral hypersensitivity is considered to be an important
pathophysiologic mechanism for common abdominal
pain symptoms in patients with functional gastrointest-
inal disorders (FGIDs) such as irritable bowel syndrome,
non-cardiac chest pain and functional dyspepsia [1]. As
visceral pain persists over time, it is thought that changes
in the central nervous system (CNS) with altered neuro-
nal processing and neural plasticity can ultimately lead to
visceral hyperalgesia [2,3], indicating there is bidirec-
tional brain-gut interaction in visceral pain [4].
The brain-gut axis is composed of ascending and des-
cending pathways where gastrointestinal sensory informa-
tion is transmitted to the brain through vagal and spinal
afferent nerves, and vice versa. There is an emerging con-
sensus that the CNS exerts a significant influence on the
clinical presentation of pain symptoms. Findings from
neuroimaging studies using functional Magnetic Reso-
nance Imaging (fMRI), Positron emission tomography
(PET) and single photon emission computed tomography
(SPECT) have shown activation of brain regions in
response to visceral pain stimulation, indicating involve-
m e n to fb r a i nf u n c t i o ni nm odulation of visceral pain
[4-8]. Although visceral hypersensitivity has been widely
demonstrated in patients, the underlying CNS mechanism
which accounts for this hypersensitivity remains unknown.
The forebrain functions to control and regulate cogni-
tive, sensory and motor processing. It has been shown
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sensory cortex, the anterior cingulated cortex (ACC) and
the insular cortex is critical for central sensitization in
the ascending pathways of visceral pain [5,9,10]. Pharma-
cological studies have shown that centrally acting antic-
onvulsant compounds are effective in animal models of
visceral pain, suggesting the involvement of neuronal
hyperexcitability in generation of visceral pain hypersen-
sitivity [11,12]. However, experimental evidence directly
connecting central alteration of cortical excitability and
sensitivity to visceral pain is lacking.
Native M-current, encoded by Kv7/KCNQ channels, is a
subthreshold voltage-gated K
+ current that serves as a
brake and suppresses abnormal ectopic discharges of neu-
rons and control neuronal hyperexcitability [13-17]. Sys-
temic activation of neuronal M-current by the Kv7/KCNQ
channel opener retigabine results in attenuation of inflam-
matory, neuropathic and visceral pain [12,18-21], and
decreases in neuronal excitability of noceiceptive neurons
and C-type nerve fibers [13,14].
In this study, we hypothesized that altered forebrain
function by enhanced neuronal excitability can influence
visceral pain. To test this concept, we generated trans-
g e n i cm i c ee x p r e s s i n gad o m i n a n t - n e g a t i v ep o r em u t a n t
of KCNQ2 that suppresses native KCNQ/M-current and
enhances membrane excitability under the control of the
forebrain specific promoter aCaMKII. Our findings show
that forebrain hyperexcitability can cause visceral hyper-
algesia, and pharmacological activation of central KCNQ/
M channel function has potential to provide a therapeu-
tic means for treatment of abdominal pain syndromes.
Results
Generation of forebrain expression of KCNQ2 G279S
mutant mice
To investigate the effect of altered forebrain excitability on
visceral pain, we generated a line of transgenic (Tg) mice
that express a dominant-negative pore mutation of the rat
Kv7.2/KCNQ2 channel (rQ2-G279S) in which a glycine
residue (Gly, G) in the selectivity filter was mutated to
Serine (Ser, S) under the control of the forebrain specific
aCaMKII promoter (Figure 1A). To confirm the domi-
nant-negative effect of mutant rQ2-G279S on wild type
(WT) channel function, we tested the ability of the mutant
to attenuate the KCNQ2 current upon co-expression in
Xenopus oocytes before the generation of transgenic mice.
Consistent with a previous report [22], co-expression of
WT KCNQ2 with the rQ2-G279S mutant resulted in sig-
nificant inhibition of the channel function (data not
shown). Real-time RT-PCR analysis of whole brain mRNA
showed expression only of rQ2-G279S mRNA in the Tg
mice without contamination of transgenic genomic DNA
bands (Figure 1B). The transgenic rQ2-G279S mRNA was
robustly distributed in forebrain regions such as the
cortex, hippocampus, and thalamus, but there was little or
no expression in the cerebellum and dorsal root ganglion
(DRG) in Tg mice (Figure 1C). In situ hybridization
further confirmed that the transgenic rQ2-G279S mRNA
was highly expressed in the forebrain (Figure 1D). These
results demonstrate that the expression of dominant-nega-
tive pore mutant (rQ2-G279S) mRNA was achieved in the
forebrain of Tg mice.
To determine whether any developmental defect was
present, we evaluated the histology of the brain in the Tg
mice. These Tg mice showed normal development of the
adult hippocampus without obvious structural changes
(Figure 1E). Moreover, these Tg mice did not develop
any obvious difference in locomotor activity behavior
(Figure 1F) or body weight, as compared with WT mice
(WT 19.05 ± 0.3980g vs Tg 19.29 ± 0.4783g at the age of
8 weeks, mean ± s.e.m., n = 8-11).
Neuronal hyperexcitability of cortex in Tg mice
To characterize neuronal excitability of Tg mice, we ana-
lyzed the electrophysiological properties of CA1 pyramidal
neurons by brain slice recordings. In neurons from WT
mice (Figure 2A, left panel), native KCNQ/M-current was
recorded with the characteristic of time-dependent deacti-
vating kinetics, which was blocked by the channel blocker
XE991 (10 μM). In contrast, the neuronal M-current in Tg
mice was much smaller than that of WT mice (Figure 2A,
right panel). Current clamp recording of action potentials
showed that WT neurons fired either no or several spikes
in the presence of 10 μM XE991, upon current injection
of 30 pA for 1000 ms (Figure 2B, left panels). In contrast,
neurons from Tg mice fired repetitive action potentials
under the same conditions (Figure 2B, right panels).
The total number of spikes was significantly increased
in neurons from Tg mice, as compared with WT mice
(Figure 2C). The resting membrane potential of Tg mice
neurons showed a shift of about 5 mV towards depolariza-
tion, as compared with WT neurons (Figure 2D). In addi-
tion, the spike firing threshold of Tg mouse neurons was
lower (Figure 2E), and the input resistance in Tg mice was
greater, as compared with WT controls (Figure 2F). These
results confirmed the neuronal hyperexcitability of hippo-
campal neurons from Tg mice.
Visceral hyperalgesia in Tg mice induced by acetic acid or
magnesium sulfate
Previous results showed there was increased excitability
of cortical neurons from Tg mice. To assess the effect of
neuronal hyperexcitability on visceral hyperalgesia, we
utilized a model of visceral pain induced by acetic acid
(AA). Intraperitoneal (i.p.) injection of 0.6% AA resulted
in a significant reduction in the onset time of writhing
and caused increased numbers of writhes, as compared
with the saline control group (Figure 3). To validate this
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Injection of different concentrations of morphine (0.6,
1.7 and 5 mg/kg, s.c.) significantly increased the onset
time of writhing and decreased the total number of
writhes (Figure 3), confirming that visceral pain was suc-
cessfully induced by 0.6% AA. To examine the visceral
pain sensitivity of Tg mice, we injected (i.p.) three differ-
ent concentrations of AA (0.3%, 0.6% and 1%) and tested
their effects on writhing. As shown in Figure 4A and 4B,
Tg mice exhibited a significant reduction in onset time
and an increased number of writhes in response to visc-
eral stimulation by 0.6% AA during a period of 15 min-
utes, as compared with WT mice. These results indicate
that Tg mice with forebrain hyperexcitability are more
susceptible to visceral pain induced by AA.
To further confirm the result obtained from the AA
test, we used another assay of visceral pain induced by
magnesium sulfate. Injection (i.p.) of magnesium sulfate
(12mg/kg) into WT mice resulted in the onset of wri-
thing which lasted for several minutes before returning
to the baseline level (Figure 4C, left panel). As com-
pared with the WT group, Tg mice exhibited a signifi-
cant increase in the number of writhes in response to
magnesium sulfate stimulus within a period of 10 min
(Figure 4C, right panel), which is consistent with the
result obtained from 0.6% AA, further confirming that
Figure 1 Generation and confirmation of transgenic mice overexpressing the KCNQ2 dominant-negative pore mutant in forebrain.A .
Schematic organization of the transgene for forebrain-specific expression of the dominant-negative mutant of rat KCNQ2-G279S (rQ2-G279S)
driven by the aCaMKII promoter. B. Identification of rQ2-G279S mRNA in the brain isolated from transgenic (Tg) and wild type (WT) mice by real
time RT-PCR (mean ± s.e.m., n = 4, *p < 0.05). The template of rQ2-G279S specific primers for detection of KCNQ2 mutant gene expression is
located in the area of SV40 poly A of the 265-plasmid (transgenic construct). The template of genomic DNA primers for detection of genomic
DNA contamination is located after SV40 poly A in the 265-plasmid (transgenic construct), which does not undergo transcription. b-actin is used
as an internal reference. C. Expression of rQ2-G279S mRNA isolated from 5 different tissues of WT and Tg mice by real time RT-PCR. The
transgene rQ2-G279S was adequately expressed in the cortex, hippocampus and thalamus, with little expression in the cerebellum, and was not
expressed in the DRG of Tg mice (mean ± s.e.m., n = 4, *p < 0.05). D. Expression of rQ2-G279S mRNA of WT (top) and Tg mice (down) using in
situ hybridyzation. The transgene rQ2-G279S was adequately expressed in the cortex, hippocampus, and thalamus, with little expression in the
cerebellum (crbl) and pons, and was not expressed in the medulla of Tg mice. The scale bar is 2mm. E. Nissl-stained coronal sections of
hippocampus. No obvious structural change was found in adult transgenic mice (a) or wild type littermates (b). Scale bar, 500 μm. F. Locomotor
activity test, no significant difference was detected in wild type (WT) and transgenic mice (Tg) in the total distance traveled during a period of
30 minutes (mean ± s.e.m., n = 7).
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deactivation currents recorded from CA1 pyramidal neurons in fresh slice preparations from wild type (WT, left panel) or transgenic mice (Tg,
right panel). Overlay of currents evoked by the protocol in the absence (black) or presence (red) of 10uM XE991. B. Response of CA1 pyramidal
neurons with injection of 1000ms, 30pA depolarizing current pulse into the cell from WT (left panels) and Tg mice (right panels) before (black)
and after (red) application of XE991. XE991 increased action potential firing in WT mice, but it was less effective in neurons from Tg mice. C.
Comparison of average number of spikes evoked by injected current in WT and Tg neurons. D-F. Box plots illustrating the differences in WT and
Tg mice in resting membrane potential, threshold current required for action potential firing and input resistance, n = 10; Data are shown as
mean ± s.e.m., *p < 0.05.
Figure 3 Validation of visceral pain induced with acetic acid. Visceral pain was induced with acetic acid in ICR species of mice. The onset
(A) and the total number of writhes (B) during a period of 15 minutes were determined after s.c. administration of morphine (0.2, 0.6, 1.7, 5 mg/
kg) 20 minutes before i.p. injection of 0.6% acetic acid. Intraperitoneal injection of 0.6% AA resulted in a significant reduction in onset time of
writhes and increased number of writhes. Morphine significantly increased the onset and decreased the total number of writhes at a dose of
0.6-5 mg/kg (mean ± s.e.m., n = 6-10, *p < 0.05, **p < 0.01, ***p < 0.001).
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by chemical stimuli.
Visceral Hyperalgesia in Tg mice induced by intracolon
injection of capsaicin
To further investigate whether altered excitability in the
forebrain affects the pain sensation of abdominal viscera
where most nerve endings are embedded deep within the
wall of the organ, an intraluminal injection of capsaicin
into the colon was performed to induce visceral pain.
Intracolon administration of vehicle solution into either
WT mice or Tg mice induced similar behavioral
responses with a small amount of abdominal licking,
which was clearly separate from normal grooming activ-
ity (Figure 5). Intracolon administration of 0.1% capsaicin
into Tg mice evoked significant behavioral responses
with abdominal licking, stretching, squashing of the
lower abdomen against floor and abdominal retractions,
as compared with the group of WT mice (Figure 5).
These results indicate that Tg mice are more sensitive to
visceral pain induced by intracolon chemical stimulation.
To investigate whether cutaneous nociceptive beha-
viors of Tg mice are also affected, we utilized two models
of thermal and inflamatory pain. In tail-withdrawal test,
both WT and Tg mice showed equal latencies to with-
draw tail from thermal stimulation with water tempera-
ture of 47°C or 49°C (Figure 6A). In another thermal test
of hot-plate, both WT and Tg mice also exhibited
an equal latency in response to nociceptive stimula-
tion applied to hindpaws on a hot plate set at 53°C
(Figure 6B). In formalin test, Tg mice showed similar
pain responses for the time spent on licking hindpaw
injected with 5% formalin in both acute and tonic phase
(Figure 6C). These results suggest that both WT and Tg
mice showed normal pain responses to cutaneous stimu-
lation by heat and inflammation.
Figure 4 Visceral hyperalgesia in transgenic mice induced by visceral stimulation of acetic acid or magnesium sulfate.A - B .T h eo n s e t
(A) and the total number of writhes (B) during a period of 15 minutes were determined after i.p. injection of 0.3%, 0.6%, 1% acetic acid (n = 7-
10). 0.6% acetic acid resulted in a shorted onset and increased number of writhes in transgenic (Tg) mice. C. Induction of visceral pain induced
by magnesium sulfate (12 mg/k g, i.p.). Tg mice displayed an increase of writhes in response to magnesium sulfate during a period of 10
minutes (mean ± s.e.m., n = 10, *p < 0.05, **p < 0.01, ***p < 0.001).
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Tg mice
Previous data indicate that visceral hyperalgesia is
mediated by enhanced forebrain activity of Tg mice. To
further confirm cortical activity is enhanced in response
to visceral pain, we examined c-Fos expression in the
forebrain cortex using immunohistochemistry. As
shown in Figure 7, the number of c-Fos-positive cells in
Figure 5 Visceral hyperalgesia in transgenic mice induced by intracolon injection of capsaicin. Behavioral reactions (abdominal licking,
stretching, squashing the lower abdomen against floor and abdominal retractions) evoked by intracolonic injection of vehicle solution or 0.1%
capsaicin in WT and Tg mice. A. Number of behaviors observed in each 5 min period over a total observation time of 20 min post-
administration. ***Indicates the other three groups which were significantly different from capsaicin-treated Tg mice during the first 5 min
observation period (p < 0.001). B. Number of behaviors observed in the total 20 min period post-administration. Data are shown as mean ± s.e.
m. (n = 5-11, *p < 0.05, **p < 0.01, ***p < 0.001).
Figure 6 Normal cutaneous pain sensitivity in transgenic mice to thermal and inflammatory stimulation.A - B .C o m p a r i s o no ft h e r m a l
sensitivity in wild type (WT) and transgenic mice (Tg) by cutaneous application of thermal stimulation. No significant difference was detected
between the two groups in tail withdrawal test (A) at 47°C and 49°C and in hot plate test (B) at 53°C (mean ± s.e.m, n = 7-11). C. The Tg mice
displayed equivalent licking/biting behavior in both the acute and tonic phases in 5% formalin test (mean ± s.e.m, n = 7-9). The acute phase of
the formalin test was defined as 0-10 min after injection and the tonic phase as 10-60 min after injection.
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increased in both WT and Tg mice after induction of
visceral pain by 0.6% AA, as compared with control sal-
ine groups. In particular, the increased number of c-
Fos-positive cells in the Tg group was even higher than
that of the WT mice in the somatosensory SII cortex
and insular cortex, but not the SI cortex (Figure 7).
These results indicate that neuronal activity of the
somatosensory SII cortex and insular cortex in the fore-
brain region of Tg mice is enhanced in response to
visceral stimulation by chemical AA.
Visceral hyperalgesia induced by intracerebroventricular
injection of Kv7/KCNQ/M channel blocker
To mimic the role of forebrain hyperexcitability in
visceral pain, we injected Kv7/KCNQ channel modula-
tors into the lateral ventricle of WT mice. Intraperito-
neal injection of 0.6% AA into WT mice resulted in
visceral pain with writhing onset time of about 6 min,
which included 9 writhes during a period of 15 min.
Intracerebroventricular (i.c.v.) injection of either retiga-
bine or XE991 had no effect on writhing onset time
(Figure 8A). The i.c.v. injection of the channel blocker
XE991 (30 nmol) into WT mice had no effect on onset
time, but significantly increased the number of writhes
(about 3-fold) (Figure 8). To further confirm this effect
of XE991, we co-injected (i.c.v.) XE991 with channel
opener retigabine into WT mice, and tested the central
effect of retigabine on visceral pain. The i.c.v. co-injec-
tion of retigabine (49 nmol) with XE991 (30 nmol) can
reverse the effect of XE991 (30 nmol), leading to a sig-
nificant reduction in writhes (Figure 8B). Together,
these results show that i.c.v. injection of blocker
XE991 can mimic visceral hyperalgesia of Tg mice,
indicating that pharmacological suppression of central
Kv7/KCNQ channel function can enhance visceral
pain, which is consistent with the previous results
obtained from Tg mice. This result also suggests that
central activation of Kv7/KCNQ channel function can
attenuate visceral pain.
Figure 7 Induction of c-fos expression in forebrain cortex by 0.6% acetic acid stimulation. A-D. Representative photomicrographs of saline
or acetic acid (i.p.) induced c-Fos expression in somatosensory SII cortex, insular cortex (IC) and SI cortex in wild type (WT) and transgenic (Tg)
mice. The scale bar for panels A1-D1 and A4-D4 is 500 μm (low magnification), and the scale bar for A2-D2, A3-D3 and A5-D5 is 100 μm (high
magnification). E1, Brain map [52] with photographed somatosensory SII and insular cortex framed in red. E2-3, Density of c-Fos positive cells in
somatosensory SII cortex (E2) and Insular cortex (E3) of WT and Tg mice treated with saline or 0.6% acetic acid (i.p.). E4, Brain map [52] with the
SI cortex framed in red. E5, Density of c-Fos positive cells in the SI cortex from WT and Tg mice treated with saline or 0.6% acetic acid (i.p.).Data
are presented as mean ± s.e.m (n = 3-4, *p < 0.05, **p < 0.01).
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Kv7/KCNQ channel opener retigabine
To further test the antinociceptive effect of retigabine, we
performed i.p. injection of retigabine and tested its effect
on visceral pain in both WT and Tg mice. Based on the
similar responses to chemical stimulation with 1% AA in
both WT and Tg groups (Figure 4B), we chose 1% AA to
induce visceral pain and tested the effect of retigabine on
the pain. Although no significant difference in onset time
was found in Tg and WT groups, WT mice showed a ten-
dency of longer onset latency when administered with
retigabine, as compared with Tg mice (Figure 9A). In WT
mice, retigabine decreased the total number of writhes
induced by 1% AA by 51% (Figure 9B). In contrast, the
antinociceptive effect of retigabine was less effective and
showed a reduction of about 13% in Tg mice. The loss of
the retigabine effect in Tg mice further confirmed the role
of the KCNQ/M-channel in the forebrain, where channel
function is important in modulation of visceral pain. The
antinociceptive effect of retigabine was reversed by XE991
at a dose of 1 mg/kg, suggesting that the effect is specifi-
cally mediated by KCNQ channel activity.
Figure 8 Effect of intracerebroventricular (i.c.v.) administration of KCNQ channel modulators on visceral pain induced by acetic acid in
wild type mice. The onset (A) and the total number of writhes (B) after induction of visceral pain by 0.6% acetic acid (i.p.) were determined
over a period of 15 min with XE991, retigabine (RTG) or vehicle administered by i.c.v. injection. XE991 (30 nmol) significantly increased the
number of writhes, and RTG (49 nmol) reversed its effect. Data are expressed as mean ± s.e.m (n = 7-13, *p < 0.05).
Figure 9 Antinociceptive effects of KCNQ channel opener retigabine on visceral pain induced by acetic acid in wild type mice, but not
transgenic mice. The onset time (A) and the total number of writhes (B) were determined with vehicle or retigabine (RTG, 7.5 mg/kg) or RTG
(7.5 mg/kg) co-injected with XE991 (1 mg/kg) administration (i.p.) before 1% acetic acid (i.p.) injection in both wild type (WT) and transgenic (Tg)
groups. Data are expressed as mean ± s.e.m (n = 8-13). RTG (7.5 mg/kg, i.p.) significantly reduced the number of writhes in WT mice, and co-
injection of RTG (7.5 mg/kg, i.p.) with XE991 (1 mg/kg, i.p.) reversed the antinociceptive effect of RTG (*p < 0.05).
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Central alteration of forebrain hyperexcitability in Tg
mice
The aim of this study was to investigate whether altered
activity of the brain can cause visceral pain hypersensitiv-
ity. Based on previously reported findings, we hypothe-
sized that cortical alteration of membrane excitability may
manifest as visceral pain hypersensitivity. However, to test
this hypothesis requires a model with central alteration in
a specific region of the brain to address the central effect
of excitability on visceral pain hypersensitivity, which is
experimentally challenging [4,23,24].
In this study, we adopted a transgenic approach by
creating a mouse model that expresses a dominant-nega-
tive mutant of the voltage-gated KCNQ potassium channel
under the control of the forebrain specific promoter
aCaMKII. The aCaMKII promoter has been successfully
used to achieve brain region specific expression of genes
of interests [25-28]. To achieve central alteration of brain
activity, we took advantage of voltage-gated Kv7/KCNQ
channels whose mutations cause idiopathic generalized
epilepsy of newborns [29,30]. Kv7/KCNQ channels are
assembled as heteromultimers to encode the native M-
current that is activated in the voltage range for action
potential initiation, and is therefore an ideal molecular tar-
get for regulating the dynamics of the neuronal firing and
excitability [13,14,31]. Suppression of M-current by mus-
carinic agonists (hence M-current) or Kv7/KCNQ blockers
such as XE991 or linopirdine can cause an increase in
intrinsic excitability [31]. By altering excitability using a
transgenic approach, we have demonstrated that forebrain
hyperexcitablity can induce visceral hyperalgesia, providing
evidence for the critical role played by central alteration of
brain-gut interaction in regulation of visceral pain.
Co-localization of aCaMKII and KCNQ2 within the
forebrain
aCaMKII is distributed throughout the forebrain, and is
abundantly expressed in hippocampus, olfactory cortex,
caudate-putamen, the septal nuclei, amygdala, thalamic
nuclei and the substantia nigra [32,33]. In layers I, II and
III of the cortex, aCaMKII shows a strong immunoreactiv-
ity [34]. KCNQ2 is expressed throughout the mouse brain,
including the cortex, hippocampus, olfactory bulb, basal
ganglia, septum and diagonal band, habenula and interpe-
duncular nucleus, thalamus reticular, lateral hypothalamic
nucleus, midbrain, pon and cerebellum [35]. Thus, expres-
sion of KCNQ2 overlaps with the aCaMKII promoter in
many areas of the forebrain such as the somatosensory
cortex, insular cortex, prefrontal cortex (PFC), hippocam-
pus and thalamus reticular. In this study, c-Fos expression
in the somatosensory SII and insular cortex in response to
acetic acid was higher in transgenenic mice than WT
mice, illustrating that neuronal activity in these brain
regions is higher in Tg mice than WT mice. Thus, neuro-
nal hyperexcitability induced by suppression of KCNQ/M
current in these forebrain regions likely manifests as visc-
eral hyperalgesia in Tg mice.
aCaMKII expression is very low on postnatal day 4
and its expression does not reach adult level until day
16 [34], indicating that the early development of the
transgenic mouse brain is most likely not affected by
overexpression of the KCNQ2 pore mutation. This was
further confirmed by our observation of normal hippo-
campal development in these transgenic mice. There-
fore, the hyperalgesia observed with visceral pain
stimulation in transgenic mice is most likely not due to
altered neuronal development.
Central sensitization mediates visceral hyperalgesia
Our transgenic mice showed activation of the c-Fos gene
in the SII and insular cortex in response to visceral stimu-
lation, but not in the SI cortex, which is consistent with
clinical neuroimaging and animal studies that show visc-
eral pain hypersensitivity and somatic sensation/pain are
mediated by different cortical areas [36,37]. It is known
that the cerebral visceral sensory/pain neuromatrix con-
sists of both lateral and medial cortical somatosensory SI/
SII areas, together with cingulate cortex/insula [9].
Somatic sensation can be localized precisely, whereas loca-
lization of visceral sensation is vague, suggesting there are
different patterns of somatic and visceral input to the cere-
bral cortex [38]. fMRI studies have shown that visceral and
somatic pain sensation is mediated by different cortical
areas. Visceral stimulation results in activation of the insu-
lar cortex, anterior and posterior cingulate cortex, second-
ary somatosensory, sensory associations and prefrontal
cortex, whereas somatic stimulation activation causes pri-
mary somatosensory cortex activation at a more superior
level [36,38-40].
In this study, brain slice recording of hippocampal pyra-
midal neurons from Tg mice confirmed the presence of
hyperexcitable properties with increased firing. Therefore,
suppression of the Kv7/KCNQ channel in the forebrain
increases neuronal excitability, and then most likely
increases synaptic strength. Increased forebrain excitability
and synaptic efficacy can produce functional changes and
mediate central sensitization, which may help explain visc-
eral hyperalgesia in KCNQ Tg mice.
Conclusions
Our findings in this study show that visceral hyperalgesia
is affected by alterations in cortical excitability, demon-
strating that dysfunction of the brain-gut axis plays an
important role in mediating visceral pain. Therefore, acti-
vation of KCNQ/M channel function has therapeutic
potential for treatment of visceral pain which causes
otherwise unexplained abdominal pain syndromes.
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Generation of transgenic mice
The dominant-negative pore mutation of rat KCNQ2
was generated by mutating the residue 279-Gly to Ser
(rQ2-G279S). rQ2-G279S cDNA was subcloned into a
265-plasmid with a forebrain-specific promoter of
aCaMKII and an SV40 poly A. The aCaMKII promoter
is specifically expressed in the forebrain and has been
widely used for genetic manipulation of region- specific
gene expression [25-28]. Transgenic mice of the
B6D2F1/Crl strain were generated by pronuclear micro-
injection of linearized rQ2-G279S DNA in fertilized
eggs. Transgenic mice were selected using genomic PCR
with transgene-specific primers (upstream 5’-GCT AGA
GGA TCT TTG TGT AAG GAA C-3’, downstream 5’-
GGA AAG TCC TTG GGG TCT TCT ACC-3’).
Expression of the transgene coding for mutant rQ2-
G279S in the forebrain was verified using real-time RT
PCR and in situ hybridization.
Animals
Female mice (both rQ2-G279S transgenic and wild type)
of 8-12 weeks age were used in this study. In one
experiment, ICR mice from the Laboratory Animal Cen-
ter, Peking University Health Science Center were also
used. Mice were housed in groups (two to five per cage)
under a controlled temperature (23 ± 2°C) and humidity
(50 ± 5%) environment with ad libitum access to food
and water. Animals were maintained on a reverse 12 h/
12 h light/dark cycle (lights on at 7:00 AM and off at
19:00 PM). The animal experimental protocols were
approved by the Animal Use and Care Committee of
Peking University and were consistent with the Ethical
Guidelines of the International Association for the Study
of Pain.
Drug administration
The Kv7/KCNQ channel opener retigabine or the
blocker XE991 (Tocris, UK) was dissolved in a mixture
of tween-80 (Sigma, St. Louis, MO, USA) and saline
(0.9% NaCl, autoclaved before use) at a ratio of 1:9 (v/
v). For intracerebroventricular (i.c.v) injection, drugs
were dissolved in DMSO and diluted with saline at a
ratio of 1:1 (v/v). Drugs were diluted to desired concen-
trations one day before experiments and were stored at
-20°C. Drug solutions were administered to mice intra-
peritoneally at a volume of 10 ml per kilogram body
weight. Injection of drug solutions and behavior testing
were conducted on the basis of a double-blind and ran-
domized manner, in which one experimenter carried out
drug injection and randomized division of mice, and
another experimenter who was blinded to drug adminis-
tration and mouse groups, conducted measurement of
pain response.
Patch clamp recordings of brain slices
Brain slices were transferred to a small volume (~0.5 ml)
recording chamber that was mounted on a fixed-stage,
upright microscope (Nikon, Japan) (IR-DIC) optics. The
recording chamber was superfused with ACSF containing
(mM): 125 NaCl, 25 NaHCO3,2 . 5K C l ,1 . 2 5N a H 2PO4,
1.5 MgCl2,1 . 0C a C l 2, 16 glucose, 1.3 Na L-ascorbate, 0.6
Na-pyruvate and saturated with 95% O2 -5 %C O 2 at a
flow rate of ~2-3 ml/min. In some current-clamp experi-
ments, 10 μmD N Q X ,5 0μmA P Va n d1 0μm Gabazine
were added to the extracellular medium to block sponta-
neous synaptic transmission. Patch electrodes were fabri-
cated from filamented, thick-walled borosilicate glass
pipettes and heat-polished to a resistance of 3~4 M when
filled with an internal solution consisting of the following
(mM): 130 K-gluconate, 10 HEPES, 0.6 EGTA, 5 KCl, 3
Na2ATP, 0.3 Na3GTP, 4 MgCl2,1 0N a 2-phosphocreatine;
pH adjusted to 7.25 with KOH. The final osmolarity of the
solution was ~290 mOsm. Liquid junction potential (~7
mV) was not corrected. Recordings were made using a
Multiclamp 700B amplifier (Molecular Devices, Union
City, CA) operating in either voltage-clamp or current-
clamp mode on the soma of CA1 pyramidal neurons. All
recordings were acquired at 5 or 10 kHz with a Digidata
1440A interface (Molecular Devices) in conjunction with a
PC, and filtered at 1 or 2 kHz, respectively, with a low-
pass Bessel filter. Stimulus generation and data acquisition
were performed using pClamp10 (Molecular Devices). The
series resistance was 10-40 MΩ in whole-cell current
clamp recording. Cells with a stable resting membrane
potential and stable AP amplitudes (> 110 mV) were used,
and all recordings were performed at room temperature
(22°C ± 2).
Locomotor activity
Locomotion was measured with the Animal Locomotor
Video Analysis System (JLBehv-LAG-8, Shanghai Jiliang
S o f t w a r eT e c h n o l o g yC o .L t d ,C h i n a ) ,w h i c hc o n s i s t so f
eight identical black plexiglass chambers (30 ‘ 30 ‘ 65 cm) in
light- and sound-controlled cubes. Each chamber was
equipped with a video camera (winfast vc100) on the top.
All cameras were connected to a PC computer for record-
ing video files of movement of mice in chambers (n = 7 per
genotype). The locomotor activity of each mouse was ana-
lyzed with the DigBehv analysis software (Shanghai Jiliang
Software Technology Co. Ltd, China) and expressed as a
total distance (cm) traveled in the period of 30 min [41].
Behavioral responses and tests for visceral and cutaneous
pain
Visceral pain induced by injection of capsaicin into the
mouse colon
The chemical capsaicin was purchased from Sigma, and
dissolved in 10% ethanol, 10% Tween 80 and 80% saline
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nol, 10% Tween 80 and 80% saline was used as the vehi-
cle. Mice were habituated to the glass observation
chambers for 30 min before experiments. Petroleum
jelly (Vaseline) was applied in the perianal area to avoid
stimulation of somatic areas by contact with the irritant
chemicals. 50 μl of chemical solution was administered by
introducing a fine cannula with a rounded tip (external
diameter 0.61 mm; 4 cm long) into the colon via the anus
[42]. Spontaneous behavior was then observed directly
over a period of 20 min. Postures defined as pain-related
behavior were (i) licking of the abdomen, (ii) stretching
the abdomen, (iii) squashing of the lower abdomen against
the floor and (iv) abdominal retractions.
Visceral pain induced by i.p. injection of acetic acid or
magnesium sulfate
After habituation in the glass observation chambers for
30 min, mice were given intraperitoneal (i.p.) injections
(10 ml/kg) with 0.3%, 0.6%, or 1% acetic acid (n = 7-10 per
genotype per concentration), and the number of length-
wise abdominal constrictions (“writhes”)w e r ec o u n t e d
over 15 min [43]. The concentration of magnesium sulfate
was 12 mg/kg (n = 10 per genotype), and the number of
writhes were counted over 10 min [23,44]. To test the
antinociceptive effect of retigabine on visceral pain, mice
received an intraperitoneal injection of vehicle or retiga-
bine (7.5 mg/kg) or retigabine (7.5 mg/kg) co-injected
w i t hX E 9 9 1( 1m g / k g )a tv o l u m eo f1 0m l / k g ,2 0m i n
prior to 1% acetic acid injection (n = 8-13, per group). The
vehicle used in this study was a mixture of tween-80
(Sigma, St. Louis, MO, USA) and saline (0.9% NaCl, auto-
claved before use) in a ratio of 1:9 (v/v).
Tail-withdrawal test
While lightly restrained in a cloth holder, the distal half of
mouse’s tail was dipped into a bath of water thermostati-
cally controlled at 47.0°C or 49.0°C (± 0.1°C) (n = 7-11,
per genotype). The latency to respond to the heat stimulus
by vigorous flexion of the tail was measured. Mice were
tested for twice, and two latency determinations (separated
by > 60 s) were measured and averaged [43].
Hot plate test
Mice were brought to testing room and allowed to accli-
matize for 10 minutes before the test begins. Pain reflexes
in response to a thermal stimulus were measured using a
Hot Plate Analgesia Meter. The surface of the hot plate
was heated to a constant temperature of 53°C (± 0.2°C).
Mice were placed on the hot plate (25.4 cm × 25.4 cm),
which is surrounded by a clear acrylic cage (19 cm tall,
close top), and the Start/Stop button on the timer is acti-
vated. The latency to respond to hindpaw flick or lick was
measured to the nearest 0.1 seconds by deactivating the
timer when the response was observed. The mouse was
immediately removed from the hot plate and returned to
its home cage. If a mouse did not respond within 60
seconds, the test was terminated and the mouse was
removed from the hot plate. Animals were tested one at a
time and were not habituated to the apparatus prior to
testing. Each animal was tested only once, because
repeated testing can lead to systematic latency alterations
[44-46].
Formalin test
After habituation to individual glass observation cham-
b e r s ,m i c ew e r eg i v e nas u b c u t a n e o u si n j e c t i o no f5 %
formalin into the plantar right hindpaw (25 μlv o l u m e )
and observed for 60 min after the formalin injection.
The presence of right hindpaw licking/biting was
recorded. The acute phase of formalin test was defined
as 0-10 min after injection and the tonic phase as 10-60
min after injection. Data are presented as the time spent
in each phase in which licking/biting was detected [43].
Intracerebroventricular (i.c.v.) injection
Intracerebroventricular (i.c.v.) injections were made
directly into the lateral ventricle (1 mm lateral and 0.4
mm caudal to the bregma at a depth of 2.5 mm) according
to modification of a previously described method [47]. For
i.c.v. injection, wild type mice were lightly anesthetized
with ethylether. XE991, retigabine or vehicle (50% DMSO
in saline) in 5 μl was injected directly into the lateral ven-
tricle 15 min before 0.6% acetic acid (i.p.) injection. After
behavioral evaluation, mice were sacrificed for examina-
tion of accuracy of the site of i.c.v injection. The dose of
XE991 used was 30 nmol or 10 nmol, and the dose of reti-
gabine was 49 nmol or 16 nmol based on our previous
study [48].
Tissue Preparations and Nissl straining
Adult mice were deeply anesthetized and transcardially
perfused with normal saline followed by 4% paraformalde-
hyde. Brains were removed and post-fixed overnight at
4°C following submersion in 20% and 30% sucrose in 0.1
M phosphate buffer. Coronal sections were cut on a cryo-
stat (Leica CM1900) into a series of 30 μm thick sections
and mounted on glass slides for Nissl straining. For of c-
Fos immunohistochemistry staining, 20 μm thick sections
were cut and stored at -20°C in a solution containing 30%
(v/v) ethylene glycol, 30% (v/v) glycerol, and 0.1 M sodium
phosphate buffer. For Nissl straining, brain slides were
stained with Nissl substance at 37°C for 1 hour and then
rinsed with water, dehydrated in alcohol series and xylene,
before coversliped with resinous mounting medium [22].
c-Fos immunoreactivity
Free-floating sections were rinsed in 0.1 M PBS (pH7.4),
incubated for 30 min in PBS containing 3% H2O2 at 37°C,
and rinsed three times for 5 min each time in PBS. After
60 min incubation in 0.3% Triton X-100 in PBS containing
12.5% goat serum, these brain sections (n = 3-4) were
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(1:1000; Santa Cruz Biotechnology). Sections were rinsed
for 5 min in PBS (three times) and incubated for 60 min
with secondary antibody (Zhongshan Golden Bridge Bio-
technology company, Beijing, China). After rinsing three
times in PBS, the reaction was detected using 3, 3’-diami-
nobenzidine (DAB). Analysis of c-Fos staining was carried
out by an observer who was blinded to the genotype and
drug treatment of the mice. Cells containing a nuclear
brown-black reaction product were considered to be c-
Fos-positive. All c-Fos-positive cells that were distinguish-
able from background staining were counted in each
region of interest within a defined area (0.01 mm
2)[ 4 9 ] .
In situ hybridization
PCR primers used for amplifying the transgene vector
SV40 probe were as follows: upstream primer 5’
GAGATGTGGCTTGGGCAG 3’ and downstream primer
5’ CATTCATCAGTTCCATAGGTT 3’; and the PCR pro-
duct was 248 bp in size. Using the Gel DNA Extraction kit
(Tiangen Biotech, Beijing, China), the resulting PCR pro-
duct was extracted from the gel and subcloned into the
pSPT18 vector with T4 ligase (Takara). The identity of the
plasmid was confirmed by DNA sequencing. The plasmid
was linearized with HindIII or EcoRI and used for RNA
transcription with T7 or Sp6 RNA polymerase to generate
antisense or sense probes, respectively, in the presence of
digoxigenin-labeled rUTP (Roche Diagnostics). Deparaffi-
nized and dehydrated paraffin-embedded tissue sections
(5 μm) were incubated in 0.1 M HCl for 10 min, and trea-
ted with Proteinase K (20 μg/ml in TBS which contains
2 mM CaCl2) for 20 min at 37°C. The slides were cooled
to room temperature, washed with TBS (150 mM NaCl,
50 mM Tris, pH7.5), fixed in 4% paraformaldehyde for 10
min, and hybridized overnight at 47°C with the SV40
cRNA probe. After hybridization, sections were washed in
2xSSC plus 50% formamide for 30 min and 2xSSC twice
for 15 min (37°C). The samples were incubated with anti-
digoxigenin antibody conjugated with alkaline phosphatase
(dilution 1:500; Roche) for 1h. 5-Bromo-4-chloro-3-indolyl
phosphate and nitro-blue-tetrazolium (Roche) were used
for the color reaction [50].
Real time RT-PCR
60 μg of RNA extracted from mouse brain were digested
with 6 μl Turbo DNase for 1 hour. cDNA was synthe-
sized using oligo dT and M-MLV reverse transcriptase
according to the manufacturer’s instructions (Invitrogen).
The PCR amplification mixtures (20 μl) contained 1 μl
template cDNA, 10 μl2×S Y B R
® Premix Ex TaqTM
(Takara) containing SYBR Green and 5 μMf o r w a r da n d
reverse primers. The sequences of these primers (for b-
actin, upstream 5’-TGT TAC CAA CTG GGA CGA C-
3’, downstream 5’-GGT GTT GAA GGT CTC AAA
CAT-3’; for rQ2-G279S, upstream 5’-CTC TGC CAC
TGG TGA AGG-3’,d o w n s t r e a m5 ’-TGT AGG TAG
TTT GTC CAA TTA TGT C-3’,f o rg e n o m i cD N Ap r i -
mers, upstream 5’-CCC ATA CAC CTC CTC TGA A-3’,
downstream 5’-CTG AAG TGT CTA CCC TTA CGG-
3’) were designed using Oligo software. The product of
the rQ2-G279S primers used to amplify the KCNQ2
mutant gene within SV40 poly A was 160 bp. The geno-
mic DNA primers located in the 265-plasmid after SV40
poly A were used to detect any contamination of trans-
genic genomic DNA with product length of 148 bp. b-
actin was used as an internal reference and the product
length was 163 bp. Amplification was carried out using
the ABI PRISM 7500™ with cycling conditions as fol-
lows: there was an initial denaturation step at 95°C for 10
s, followed by 40 cycles at 95°C for 5 s and 60°C for 34 s
with fluorescent detection at 60°C. Melting curve analysis
was performed from 60°C to 95°C in 1°C step. Results
were analyzed using the 2
-ΔΔCt method to compare
expression of genes of interest with that of b-actin [51].
Data analysis
Statistical analysis was performed with GraphPad Prism
(the 5th edition) and SPSS 13.0 for Windows. All data
are presented as mean ± s.e.m. Statistical significance
between multiple groups was examined by the Student’s
t test or one-way or two-way ANOVA with an appropri-
ate post hoc test. A value of p < 0.05 was considered to
be statistically significant.
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